Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Young TIL Therapy for Metastatic Melanoma
NCT01993719Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2013
- Primary completion
- Oct 2021
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of young tumor-infiltrating lymphocytes in melanoma, sponsored by National Cancer Institute. Started Dec 2013; status: completed.
02
Drugs
young tumor-infiltrating lymphocytes
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01993719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01993719.